9:00am - 5:00pm

Our Opening Hours Mon. - Fri.

1.800.799.2234

Call Us For Free Consultation

Facebook

Twitter

Search
 

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Top West Virginia Mesothelioma Lawyer | Law Firm | Attorney | GPW > Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Cediranib Maleate in Treating Patients With Malignant Mesothelioma That Cannot Be Removed By Surgery

Estimated reading time: < 1 min

Condition: Advanced Malignant Mesothelioma

Estimated Enrollment: 51

Gender: All

Min Age: 18 Years

Age Group: Adult, Older Adult

Current Status: Completed

Study Results: Has Results

Outcome Measures: Objective Response Rate, Complete (CR) or Partial (PR) Response,  Changes in Laboratory Correlates,  Pharmacogenomics by Correlating Genetic Polymorphisms With Drug Activity and Toxicity,

Interventions: cediranib maleate,

Phase:

Study Type: Interventional

Study Design: Intervention Model: Single Group Assignment, Masking: None (Open Label), Primary Purpose: Treatment,

Primary Completion Date: September 2010

Completion Date: September 2010

Last  Posted Date: July 31, 2014

Location: University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Website Link: https://ClinicalTrials.gov/show/NCT00309946

Was this article helpful?
Dislike 0